FDA Approved: ERTAPENEM — Supplemental Application (Eugia US LLC)

View source ↗

Summary

The FDA approved a supplemental application for ertapenem submitted by Eugia US LLC, authorizing changes to its approved labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Complicated Intra-abdominal Infection
• Complicated Skin and Skin Structure Infection
• Gynecologic Infection

Drugs mentioned

• ERTAPENEM (ertapenem)

Snippet

SUPPL AP for ERTAPENEM (ERTAPENEM)